Aligos Therapeutics, Inc. (ALGS)
Nasdaq: ALGS · CIK 0001799448 · United States
Every official Aligos Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ALGS filings
Aligos Therapeutics, Inc. documents
- Aligos Therapeutics, Inc. 10-K 2026ALGS 10-K 2026: annual report for fiscal 2026
- Aligos Therapeutics, Inc. 10-K 2025ALGS 10-K 2025: annual report for fiscal 2025
- Aligos Therapeutics, Inc. 10-K 2024ALGS 10-K 2024: annual report for fiscal 2024
- Aligos Therapeutics, Inc. 10-K 2023ALGS 10-K 2023: annual report for fiscal 2023
- Aligos Therapeutics, Inc. 10-K 2022ALGS 10-K 2022: annual report for fiscal 2022
- Aligos Therapeutics, Inc. 10-Q 2026ALGS 10-Q 2026: quarterly report for fiscal 2026
- Aligos Therapeutics, Inc. 10-Q 2025ALGS 10-Q 2025: quarterly report for fiscal 2025
- Aligos Therapeutics, Inc. 10-Q 2024ALGS 10-Q 2024: quarterly report for fiscal 2024
- Aligos Therapeutics, Inc. 10-Q 2023ALGS 10-Q 2023: quarterly report for fiscal 2023
- Aligos Therapeutics, Inc. 10-Q 2022ALGS 10-Q 2022: quarterly report for fiscal 2022
- Aligos Therapeutics, Inc. 8-K 2026ALGS 8-K 2026: current report for fiscal 2026
- Aligos Therapeutics, Inc. 8-K 2025ALGS 8-K 2025: current report for fiscal 2025
- Aligos Therapeutics, Inc. 8-K 2024ALGS 8-K 2024: current report for fiscal 2024
- Aligos Therapeutics, Inc. 8-K 2023ALGS 8-K 2023: current report for fiscal 2023
- Aligos Therapeutics, Inc. 8-K 2022ALGS 8-K 2022: current report for fiscal 2022
- Aligos Therapeutics, Inc. DEF 14A 2026ALGS DEF 14A 2026: proxy statement for fiscal 2026
- Aligos Therapeutics, Inc. DEF 14A 2025ALGS DEF 14A 2025: proxy statement for fiscal 2025
- Aligos Therapeutics, Inc. DEF 14A 2024ALGS DEF 14A 2024: proxy statement for fiscal 2024
- Aligos Therapeutics, Inc. DEF 14A 2023ALGS DEF 14A 2023: proxy statement for fiscal 2023
- Aligos Therapeutics, Inc. DEF 14A 2022ALGS DEF 14A 2022: proxy statement for fiscal 2022
- Aligos Therapeutics, Inc. Form 4 2026ALGS Form 4 2026: insider trading filing for fiscal 2026
- Aligos Therapeutics, Inc. Form 4 2025ALGS Form 4 2025: insider trading filing for fiscal 2025
- Aligos Therapeutics, Inc. Form 4 2024ALGS Form 4 2024: insider trading filing for fiscal 2024
- Aligos Therapeutics, Inc. Form 4 2023ALGS Form 4 2023: insider trading filing for fiscal 2023
- Aligos Therapeutics, Inc. Form 4 2022ALGS Form 4 2022: insider trading filing for fiscal 2022
- Aligos Therapeutics, Inc. S-1 2026ALGS S-1 2026: registration statement for fiscal 2026
- Aligos Therapeutics, Inc. S-1 2025ALGS S-1 2025: registration statement for fiscal 2025
- Aligos Therapeutics, Inc. S-1 2024ALGS S-1 2024: registration statement for fiscal 2024
- Aligos Therapeutics, Inc. S-1 2023ALGS S-1 2023: registration statement for fiscal 2023
- Aligos Therapeutics, Inc. S-1 2022ALGS S-1 2022: registration statement for fiscal 2022
- Aligos Therapeutics, Inc. 13F 2026ALGS 13F 2026: institutional holdings for fiscal 2026
- Aligos Therapeutics, Inc. 13F 2025ALGS 13F 2025: institutional holdings for fiscal 2025
- Aligos Therapeutics, Inc. 13F 2024ALGS 13F 2024: institutional holdings for fiscal 2024
- Aligos Therapeutics, Inc. 13F 2023ALGS 13F 2023: institutional holdings for fiscal 2023
- Aligos Therapeutics, Inc. 13F 2022ALGS 13F 2022: institutional holdings for fiscal 2022
More companies